MedTrace Logo

Effects of Hip and Ankle Mobility Rehabilitation in Male Collegiate Athletes With Patellofemoral Pain

NCT07542236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-04-30

No results posted yet for this study

Summary

This study evaluates whether a 6-week hip- and ankle-mobility-based rehabilitation program can improve pain, knee-related function, neuromuscular coordination, and physical performance in male soccer players with patellofemoral pain. Patellofemoral pain is a common condition in soccer players and may affect training tolerance, movement control, and sports performance. In this randomized controlled trial, participants are assigned to either an intervention group receiving hip- and ankle-mobility-based rehabilitation in addition to regular soccer training or a control group continuing regular soccer training alone. The rehabilitation program is performed 3 times per week for 6 weeks. Main outcomes include pain intensity and knee-related function. Additional outcomes include hip and ankle range of motion, vastus medialis-vastus lateralis onset timing, Y-Balance Test performance, and countermovement jump height. This study aims to determine whether improving proximal and distal joint mobility can contribute to better clinical and functional recovery in soccer players with patellofemoral pain.

Conditions

  • Patellofemoral Pain

Interventions

BEHAVIORAL

Hip- and Ankle-Mobility-Based Rehabilitation Program

A 6-week rehabilitation program performed 3 times per week for approximately 30 minutes per session. The program includes standardized warm-up, hip mobility training, ankle mobility training, and integrated movement exercises designed to improve hip internal and external rotation mobility, ankle dorsiflexion, and lower-limb movement control in soccer players with patellofemoral pain.

Sponsors & Collaborators

  • Beijing Sport University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-03-02
Completion
2026-03-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07542236 on ClinicalTrials.gov